Janus kinase inhibition for autoinflammation in patients with DNASE2 deficiency

J Allergy Clin Immunol. 2020 Feb;145(2):701-705.e8. doi: 10.1016/j.jaci.2019.11.020. Epub 2019 Nov 24.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoimmune Diseases / drug therapy*
  • Autoimmune Diseases / genetics*
  • Azetidines / therapeutic use*
  • Child
  • Deoxyribonucleases / deficiency
  • Deoxyribonucleases / genetics*
  • Female
  • Humans
  • Janus Kinase Inhibitors / therapeutic use*
  • Mutation, Missense
  • Pedigree
  • Purines
  • Pyrazoles
  • Sulfonamides / therapeutic use*

Substances

  • Azetidines
  • Janus Kinase Inhibitors
  • Purines
  • Pyrazoles
  • Sulfonamides
  • Deoxyribonucleases
  • DNASE2 protein, human
  • baricitinib